TNF and obesity due to melanocortin 4 receptor deficiency: In people with inflammatory arthritis, systematic reviews also demonstrate that obesity is associated with a reduced likelihood of achieving remission/minimal disease activity [5, 32] and responding to anti-TNF therapy [33].